Defence Therapeutics Inc. (DTCFF)
OTCMKTS
· Delayed Price · Currency is USD
0.6447
0.00 (0.00%)
At close: Apr 10, 2025
Defence Therapeutics Market Cap
Defence Therapeutics has a market cap or net worth of $35.11 million as of April 24, 2025. Its market cap has decreased by -43.03% in one year.
Market Cap
35.11M
Enterprise Value
35.95M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.64
Market Cap Chart
Since May 7, 2021, Defence Therapeutics's market cap has decreased from 73.36M to 35.11M, a decrease of -52.13%. That is a compound annual growth rate of -16.96%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2025 | 35.11M | 60.49% |
Dec 31, 2024 | 21.88M | -72.11% |
Dec 29, 2023 | 78.46M | 7.90% |
Dec 30, 2022 | 72.71M | -52.72% |
Dec 31, 2021 | 153.80M | 109.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SS Innovations International | 1.69B |
Endo Inc. | 1.63B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 704.15M |
Northwest Biotherapeutics | 489.55M |
Elite Pharmaceuticals | 449.74M |
Glass House Brands | 419.36M |
CytoDyn | 251.42M |